UPDATED May 11, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
LOOP | US$2.83 | -0.9% | -3.4% | US$134.5m | US$7.25 | PS1113.1x | E65.6% | n/a | ||
ASPN | US$27.01 | 7.6% | 253.5% | US$2.1b | US$27.50 | PS7.2x | E53.8% | n/a | ||
LZM | US$6.66 | -6.5% | -37.8% | US$532.8m | US$14.47 | PS360.5x | E112.5% | n/a | ||
MP | US$16.13 | 4.7% | -24.3% | US$2.7b | US$24.18 | PE796.2x | E63.4% | n/a | ||
ATLX | US$15.56 | 7.8% | -18.9% | US$227.8m | US$43.67 | PB25.6x | E99.2% | n/a | ||
BLGO | US$0.35 | 2.2% | 77.1% | US$104.4m | n/a | PS8.5x | E109.6% | n/a | ||
SGML | US$17.13 | 7.2% | -56.5% | US$1.9b | US$25.07 | PS14.3x | E145.1% | n/a | ||
ALTM | US$4.65 | -0.6% | -56.1% | US$5.0b | US$8.15 | PE21.7x | E35.5% | n/a | ||
GROY | US$1.81 | -4.7% | -14.6% | US$264.1m | US$3.49 | PS86.6x | E84.4% | 0% | ||
LOMA | US$7.68 | 3.5% | 22.1% | US$896.2m | US$7.56 | PE76.8x | E72.9% | 2.2% | ||
MTAL | US$13.12 | 2.1% | 27.6% | US$909.9m | US$15.51 | PS5.7x | E76.6% | n/a | ||
OLN | US$55.31 | 3.1% | 5.3% | US$6.6b | US$61.63 | PE18.7x | E33.8% | 1.4% | ||
RGLD | US$127.24 | 4.0% | -6.8% | US$8.4b | US$151.17 | PE37.6x | E26.8% | 1.3% | ||
NTIC | US$18.95 | 6.2% | 66.2% | US$178.7m | US$20.00 | PE38.9x | E41.2% | 1.5% | ||
SUM | US$40.61 | 2.9% | 29.1% | US$7.1b | US$50.93 | PE28.5x | E29.7% | n/a | ||
MTRN | US$115.72 | 7.9% | 13.9% | US$2.4b | US$151.00 | PE28.7x | E30.7% | 0.4% | ||
FSI | US$2.07 | -2.1% | -27.6% | US$25.8m | US$5.00 | PE9.3x | E27.9% | 0% | ||
OEC | US$25.07 | 6.2% | 4.8% | US$1.5b | US$29.83 | PE16.6x | E23.4% | 0.3% | ||
CC | US$28.90 | 8.8% | 2.1% | US$4.3b | US$30.56 | PB5.7x | E81.9% | 3.5% | ||
CSTM | US$20.24 | 0.1% | 37.5% | US$3.0b | US$25.43 | PE22.8x | E37.8% | n/a | ||
CDE | US$5.29 | 8.4% | 58.4% | US$2.1b | US$5.37 | PS2.5x | E109.8% | n/a | ||
CRS | US$104.67 | 1.0% | 115.1% | US$5.2b | US$128.00 | PE39.6x | E42.2% | 0.8% | ||
AXTA | US$36.04 | 2.4% | 19.9% | US$8.0b | US$39.33 | PE32.1x | E23.5% | n/a | ||
BIOX | US$12.91 | 6.3% | 11.9% | US$811.1m | US$20.25 | PE36.9x | E37.2% | n/a |